Similar articles for PMID: 23321458

Year	Number of Results
1981	1
1982	1
1987	1
1991	2
1993	2
1995	2
1996	2
1997	3
1998	3
1999	1
2000	4
2002	2
2003	2
2004	10
2005	6
2006	3
2007	4
2008	4
2009	4
2010	9
2011	11
2012	21
2013	20
2014	23
2015	35
2016	37
2017	44
2018	47
2019	35
2020	40
2021	42
2022	26
2023	13
2024	0

1

Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.

Mattner F, Staykova M, Berghofer P, Wong HJ, Fordham S, Callaghan P, Jackson T, Pham T, Gregoire MC, Zahra D, Rahardjo G, Linares D, Katsifis A. Mattner F, et al. J Nucl Med. 2013 Feb;54(2):291-8. doi: 10.2967/jnumed.112.108894. Epub 2013 Jan 15. J Nucl Med. 2013. PMID: 23321458 Free article.

2

In vivo imaging of CNS microglial activation/macrophage infiltration with combined [¹⁸F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis.

Coda AR, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G, Annunziato L, Salvatore M, Brunetti A, De Berardinis P, Quarantelli M, Palma G, Pappatà S. Coda AR, et al. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):40-52. doi: 10.1007/s00259-020-04842-7. Epub 2020 May 7. Eur J Nucl Med Mol Imaging. 2021. PMID: 32378022 Free PMC article.

3

Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS).

Constantinescu CS, Lavi E. Constantinescu CS, et al. Curr Eye Res. 2000 Jan;20(1):71-6. Curr Eye Res. 2000. PMID: 10611718

4

Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.

Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H. Whitham RH, et al. J Immunol. 1991 Jan 1;146(1):101-7. J Immunol. 1991. PMID: 1701788

5

¹⁸F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis.

Belloli S, Zanotti L, Murtaj V, Mazzon C, Di Grigoli G, Monterisi C, Masiello V, Iaccarino L, Cappelli A, Poliani PL, Politi LS, Moresco RM. Belloli S, et al. J Neuroinflammation. 2018 Feb 5;15(1):33. doi: 10.1186/s12974-017-1044-x. J Neuroinflammation. 2018. PMID: 29402285 Free PMC article.

6

Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.

Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. Begolka WS, et al. J Immunol. 1998 Oct 15;161(8):4437-46. J Immunol. 1998. PMID: 9780223

7

In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis.

Airas L, Dickens AM, Elo P, Marjamäki P, Johansson J, Eskola O, Jones PA, Trigg W, Solin O, Haaparanta-Solin M, Anthony DC, Rinne J. Airas L, et al. J Nucl Med. 2015 Feb;56(2):305-10. doi: 10.2967/jnumed.114.149955. Epub 2015 Jan 8. J Nucl Med. 2015. PMID: 25572093 Free article.

8

Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.

Berard JL, Wolak K, Fournier S, David S. Berard JL, et al. Glia. 2010 Mar;58(4):434-45. doi: 10.1002/glia.20935. Glia. 2010. PMID: 19780195

9

The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.

Leva G, Klein C, Benyounes J, Hallé F, Bihel F, Collongues N, De Seze J, Mensah-Nyagan AG, Patte-Mensah C. Leva G, et al. Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3016-3027. doi: 10.1016/j.bbadis.2017.09.007. Epub 2017 Sep 9. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28899788 Free article.

10

[(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model.

Xie L, Yamasaki T, Ichimaru N, Yui J, Kawamura K, Kumata K, Hatori A, Nonomura N, Zhang MR, Li XK, Takahara S. Xie L, et al. J Neuroimmune Pharmacol. 2012 Mar;7(1):231-42. doi: 10.1007/s11481-011-9322-3. Epub 2011 Oct 29. J Neuroimmune Pharmacol. 2012. PMID: 22038158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

395 results

Results by year